Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population

OBJECTIVES: With the approval of new non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation (NVAF), it is anticipated that their introduction may change NVAF treatment patterns; however, there is limited supporting real-world evidence. This study inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Willey, Vincent, Franchino-Elder, Jessica, Fu, An-Chen, Wang, Cheng, Sander, Stephen, Tan, Hiangkiat, Kraft, Elizabeth, Jain, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042605/
https://www.ncbi.nlm.nih.gov/pubmed/29961012
http://dx.doi.org/10.1136/bmjopen-2017-020676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042605/
https://www.ncbi.nlm.nih.gov/pubmed/29961012
http://dx.doi.org/10.1136/bmjopen-2017-020676

Ejemplares similares